Gold just glistened into all-time highs.

The smartest play isn’t coins, it’s the operator with scale, low costs, and real torque to price.

If bullion holds here, expect free cash, buybacks, and estimates to move higher.

For years, crypto faced unclear rules and nonstop skepticism.

That ended in July.

Congress passed landmark legislation, and within days the market blasted to a record $4 trillion.

Why? Because institutions finally have clarity.

Banks and Wall Street are free to move in—something retail investors rarely get a chance to front-run.

Our free book, Crypto Revolution, explains what this shift means and how to prepare before adoption accelerates.

It also comes with $788 in free bonus resources.

This isn’t hype—it’s history in the making.

[Download Your Free Copy Now]

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.

👉 Click here to get our weekly Sunday watchlist sent to your cell for free!

Hewlett-Packard Enterprise

Ticker: HPE | Market Cap: $29.7B

| Catalyst: Post-analyst-day reset meets valuation tug-of-war

An 8% slide after the Securities Analyst Meeting says expectations got ahead of the story. HPE laid out growth aims in servers, storage, and networking (including high-performance compute and hybrid cloud), but the room wanted Arista- or Dell-level oomph. 

Financials are fine, not fabulous. Low single-digit revenue compound annual growth rate (CAGR) lately, margins inching higher, and a dividend that pays you to be patient. The Altman Z and liquidity metrics aren’t love notes, but a balanced leverage profile and recurring service mix help. 

At ~2.3% yield and a P/E flirting with cycle highs, it’s a show-me stretch, yet dips on guidance haircuts can set up decent entries if orders and AI-adjacent compute stay resilient.

What you should watch: Order intake and backlog in AI/HPC nodes, GreenLake Annual Recurring Revenue (ARR) growth, and any commentary on pricing vs. component costs. If management converts the pipeline to cleaner revenue growth while protecting gross margin, the post-SAM sulk can fade.

Thousands of stocks were analyzed — only five made the cut.

This exclusive new report, “5 Stocks Set to Double,” highlights the companies that could be positioned for breakout growth as market trends shift heading into the new year.

Each one is backed by strong fundamentals and promising technical setups that could make early investors smile.

Past reports following this same system uncovered stocks that soared +175%, +498%, even +673%.

Download your free “5 Stocks Set to Double” report now before the clock hits midnight.

Your next big winner might be waiting inside.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Capital One

Ticker: COF | Total Assets: $129.9B | Catalyst: Q3 print with Discover integration + provisions in focus

Earnings land Oct. 21 after the bell, and the tape will obsess over three things: Net Interest Income (NII), fees, and provisions. The good news is that NII should benefit from loan growth and a near-steady rate backdrop for most of the quarter. 

Fee lines (interchange and service charges) likely pop with higher card usage and the Discover deal. The drag is operating expenses and credit costs are up as macro wobbles, inflation’s tariff aftershocks hang around, and portfolios season. 

The headline P/E looks bonkers right now (deal noise and reserve math), but that’s why the quarter matters: clarity can compress the optical multiple fast. COF’s surprise track record is solid; just don’t forget it’s still a credit cycle stock.

What you should watch: Net charge-offs, 30/90-day delinquencies, reserve build methodology, and Discover synergy run-rate updates. If credit metrics stabilize and revenue synergies show up on time, the stock can re-rate despite a heavier expense base.

Cooper Companies

Ticker: COO | Market Cap: $14.2B | Catalyst: Lens mix shift, buyback firepower, and myopia optionality

The contact lens market remains wonderfully boring, but in the best way. It’s defensive, sticky, and quietly tilting to higher-value silicone hydrogel (SiHy) dailies, where Cooper’s portfolio is loaded.

Stifel stays constructive with an $85 target and highlighted strong physician diligence; management also expanded its buyback authorization to $2B, which is non-trivial at this size. Near term, investors are still digesting a guidance reset and a mixed quarter, so sentiment is bruised. 

Medium term, increased manufacturing capacity for MyDay and a vast pediatric myopia market (MiSight and the broader management suite) can reset growth optics.

What you should watch: Daily SiHy share gains, pricing and promo discipline versus big peers, and myopia management adoption (prescriber training + insurance coverage anecdotes). If free cash flow inflects with lens mix and buybacks stay active, the multiple has room to heal.

Some stocks take months or years to move.

Others? They can move in weeks.

That’s why we’ve just released a FREE report: 7 Best Stocks for the Next 30 Days.

Less than 5% of all publicly traded companies meet the strict criteria to make this list.

These are hand-selected from thousands of candidates — the very best positioned for potential short-term upside.

If you’re looking for fresh ideas to fuel your next trade, this is the list to start with.

[Download your FREE copy now] before you place your next trade.

Timing is everything in the market.

Don’t wait until these moves are yesterday’s news.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Mettler-Toledo

Ticker: MTD | Market Cap: $28.0B | Catalyst: Quality-control tailwinds and a valuation debate after a beat

The precision instruments leader just delivered above-consensus results with broad-based segment strength, reminding everyone why the franchise commands a premium. 

The cross-current is some models flag modest undervaluation while discounted cash flow (DCF) purists see it a touch rich, classic which spreadsheet are we using energy. 

The bigger picture is cleaner: tighter regulatory standards in life sciences and food, more automated QA/QC, and rising demand for audit-proof analytics support steady mix and pricing. China/Europe macro is still the wobble, but MTD’s execution through mud is the feature.

What you should watch: Orders and book-to-bill in pharma/bioprocess, pricing vs. elasticity, and any incremental service/consumables attach that fattens recurring revenue. If backlog converts and regional headwinds ease even a little, operating leverage can surprise on the upside.

Newmont

Ticker: NEM | Market Cap: $107.9B | Catalyst: Record gold prices powering operating leverage

Gold just printed fresh highs, and Newmont, still the global production heavyweight, is doing what it does when the metal runs: expanding margins and sentiment at the same time. 

Shares have ripped this week and now push 52-week highs, but the fundamental driver is straightforward. Tighter macro nerves (trade frictions, budget drama, correction chatter) are funneling flows into bullion, and miners are the torque.

Newmont produced ~6.8M oz last year and expects ~5.9M oz for 2025, with AISC discipline, every $100/oz in price is meaningful to free cash flow. Yes, the multiple is richer than the trailing average, but in cycles like this, price > model.

What you should watch: Updated 2025–26 production and cost guidance versus realized pricing, hedging disclosures (or lack thereof), and any capital returns cadence (dividends/buybacks) tied to the windfall. If spot holds near recent highs into Q4, estimates likely have more catching up to do.

Final Word

Different lanes, same play. Let catalysts do the talking. If gold glitters, Newmont’s math stays simple. If HPE converts pipeline into cleaner growth, the post-meeting hangover fades. 

If Capital One’s credit holds while Discover synergies show, the optical P/E deflates. If Cooper executes on SiHy dailies and myopia, multiple repair follows. And if Mettler keeps compounding through choppy geographies, you own a quality engine. 

Pick your fighter, size your risk, and let numbers drive the next move.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.